Icon
+91 94997 68112
Login Register

AGGRASTAT - (12.5mg/250ml; Injection)

TIROFIBAN HYDROCHLORIDE Medicure Inc.
12.5mg/250ml; Injection
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Used to prevent blood clots that can cause a heart attack or other serious blood flow problems.
Yes
***** ****** ** ***. ***** ****** ***** * **** ** ** ****** ******* (*** *, ****) *** *** *********. *****, ***** ***** **** ***** ****** ********* '*** ******. ********** ******* **** ***** ****** *** ********* ** **********, ** *** ****** ******* ********* ** ** ** ***** *, ****. ****, ***** ****** ***** * **** ** ** '*** ****** *** *** *********. ** ****** **** **** ***** ****** **** ****** ** **** ****. ***** ****** **** ** ****** '*** *** ******** ******* **** ***** ****** ** ***** *******. ********* ** **********, ***** ****** *** ****** *** *******(**.* ** ********) ** *** *, ****. *****, ********* ***** * **** ** *** *** *********.
AGGRASTAT Patent 1 Patent 2
***** ****** ******* ******* ***** **** ** **
***** ****** ******* ******* ***** **** ** **
********* *** ********* ********* ** **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** ****** *** \ ** *** **, **** **** ******* ***** ***** ****** **** ** ** ******** ******** ** *** **, ****
***** ****** ** \ ** *** *, **** **** *******/ **** ** ** ******** *** ****** *******
********* ** \ ** *** **, **** ********* ** **** *** ******** ******** ** *** **, ****
  1. *** **, **** : ******** ***** * **** ******* ***** ****** **** ****** ******* (*** *, ****) ** ** ** *** ******.
  2. *** **, **** : ***** ***** **** ******* (*** *, ****) ****** *** ********* ** ***********. ********** ******* **** ***** ****** *** ********* ** **********, ** *** ****** ******* ********* ** ** ** ***** *, ****
  3. *** *, **** : ******** ***** * **** ******* ***** ****** **** ****** ******* (*** *, ****) ** ** ** *** ******.
  4. *** **, **** : ***** ****** **** ** ****** '*** *** ** ******* **** ******** . ********* ** **********, ***** ****** *** ****** *** ******* ** *** *, ****
  5. *** **, **** : ******** ***** * **** ******* ********* ** ****** '***.
  6. *** **, **** : ********* ********* *** **** ** *********** ** ****** '*** ** **** ***.

AGGRASTAT - (5 mg/100 ml; Injection)

TIROFIBAN HYDROCHLORIDE Medicure Inc.
5 mg/100 ml; Injection
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Aggrastat is indicated for the prevention of early myocardial infarction in adult patients presenting with acute coronary syndromes without ST elevation (NSTE-ACS) with the last episode of chest pain occurring within 12 hours and with ECG changes and/or elevated cardiac enzymes.
Yes
***** ****** ** ***. ***** ****** ***** * **** ** ** '*** ****** *** *** *********. ** ****** **** **** ***** ****** **** ****** ** **** ****. ***** **** ** ****** '*** *** ******* **** ******** ** ***** *******. ********* ** **********, ***** ****** *** ****** *** *******(* ** ********) ** *** *, ****. *****, ********* ***** * **** ** *** *** *********.
AGGRASTAT Patent 1 Patent 2
***** ****** ******* ******* ***** **** ** **
********* *** ********* ********* ** **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** ****** *** \ ********* *** *, **** **** ******* ***** ***** ****** **** ** ** ******** *** ****** *******
********* ** \ ** *** **, **** ********* ** **** *** ******** ******** ** *** **, ****
  1. *** *, **** : ******** ***** * **** ******* ***** ****** **** ****** ******* (*** *, ****) ** ** ** *** ******.
  2. *** **, **** : ***** ****** **** ** ****** '*** *** ** ******* **** ******** . ********* ** **********, ***** ****** *** ****** *** ******* ** *** **, ****
  3. *** **, **** : ******** ***** * **** ******* ********* ** ****** '***.
  4. *** **, **** : ********* ********* *** **** ** *********** ** ****** '*** ** **** ***.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.